Drugs for Neurodegenerative Diseases Flashcards
L-DOPA
Increase DA synthesis Dopamine precursor, crosses BBB Oral, rapidly absorbed in SI Short half-life Tx: Parkinson's SE: caused by peripheral conversion to NE--nausea, vomiting, anorexia, cardiac arrhythmias, orthostatic hypotension. Hallucinations, dyskinesia, mood changes, etc.
L-DOPA + carbidopa
Drug of choice for Parkinsons!
Increase DA synthesis
Tx: Parkinson’s
Entacapone
Increase DA synthesis
Inhibits COMT (decreases metabolism of LDOPA)
Only works in periphery
Tx: Parkinson’s
Apomorphine
DA receptor agonist
Only subcutaneous injection!
Tx: Parkinson’s
SE: nausea, vomiting, arrhythmias, postural hypotension, hallucinations, sleepiness
Bromocriptine
D2 agonist and D1 partial agonist
Activates D1 receptor
Oral
Tx: Parkinson’s
Pramipexole
D2 and D3 agonist
Activates D2 receptor
Oral
Tx: Parkinson’s
Ropinirole
D2 and D3 agonist
Activates D2 receptor
Oral
Tx: Parkinson’s
Amantadine
Moderately increases DA release, blocks cholinergic muscarinic receptors and NMDA receptors
Tx: Parkinson’s, bradykinesia, rigidity
SE: hallucinations, confusion, nausea, dizziness, rash on lower limbs.
Don’t prescribe to heart disease and glaucoma patients!
**Antiviral drug for treatment of Flu!
Benztropine
Antagonist of muscarinic cholinergic receptor
Tx: Parkinson’s, tremors, rigidity, NOT bradykinesia
SE: antimuscarinic effects
Trihexyphenidyl
Antagonist of muscarinic cholinergic receptor
Tx: Parkinson’s, tremors, rigidity, NOT bradykinesia
SE: antimuscarinic effects
Rasagiline
Decrease DA catabolism
Inhibitor of MAO-B
Tx: Parkinson’s
Selegiline
Decrease DA catabolism MAOI (B type inhibitor) Decreases production of H2O2 Oral Half-life= 7-9 hrs Pee it out Metabolized to Methamphetamine and amphetamine Tx: Parkinson's
Donepezil
AChE inhibitor
Long acting
Metabolized by CYP3A4 and CYP2D6
Tx: Alzheimer’s
Galantamine
AChE inhibitor
Metabolized by CYP3A4 and CYP2D6
Tx: Alzheimer’s
Rivastigmine
AChE inhibitor
Short acting
Metabolized by plasma cholinesterase
Tx: Alzheimer’s